ALVIO — Valerio Therapeutics SA Cashflow Statement
0.000.00%
Last trade - 00:00- €195.03m
- €201.58m
- €2.57m
Annual cashflow statement for Valerio Therapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.94 | -19.6 | -20.3 | -23.9 | -4.9 |
| Depreciation | |||||
| Non-Cash Items | 0.89 | 2.96 | 2.4 | -0.219 | 0.384 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.04 | 7.16 | -0.649 | 4.47 | 1.46 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.57 | -9.44 | -18.6 | -8.37 | 1.84 |
| Capital Expenditures | -0.139 | -0.488 | -0.183 | -0.319 | -1.32 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.073 | 0.079 | 0.006 | -1.07 | 0.154 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.066 | -0.409 | -0.177 | -1.39 | -1.16 |
| Financing Cash Flow Items | 0.004 | 0.002 | -0.007 | — | 0.003 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12 | 6.46 | 10.8 | 4.21 | -0.774 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.36 | -3.3 | -7.77 | -5.66 | -0.101 |